Skip to content

Clinical trials

Phase 3 Peripheral Arterial Disease trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Peripheral Arterial Disease Phase: Phase 3 Country / region: Germany Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20102
20111
20122
20131
20151
20171
20181
20201
20211
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Active, not recruiting1
Recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer3
AstraZeneca1
AtheroMed, Inc1
CSL Behring1
Eli Lilly and Company1
Eurocor GmbH1
Ixaka Ltd1
Ludwig-Maximilians - University of Munich1
Novo Nordisk A/S1
Population Health Research Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Peripheral Arterial Disease14
Atherosclerosis4
Cardiovascular Diseases3
Coronary Artery Disease3
Diabetes Mellitus, Type 23
Heart Diseases3
Peripheral Vascular Diseases3
Stroke3
Cerebrovascular Disorders2
Chronic Limb-Threatening Ischemia2

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.